The amygdala is a key limbic structure strongly implicated in both epilepsy and anxiety disorders. Epilepsy-like mechanisms involve an increased glutamatergic activity, whereas disturbances in serotonin [5-hydroxytryptamine (5-HT)] systems are associated with anxiety-like behavior. Previous studies suggest that low 5-HT increases amygdala excitability, but the molecular mechanisms are not well characterized. Herein we explore the ability of low serotonin to increase glutamate receptor transcription. Using quantitative reverse transcriptase-polymerase chain reaction, we found that rats treated with P-chlorophenylalanine, an inhibitor of tyrosine-5hydroxylase, resulted in a 21-fold increase in glutamate receptor 1 (GluR1) mRNA expression in the amygdala. These results suggest that low 5-HT induces hyperexcitability of amygdala neurons by increasing GluR1 transcription, and the upregulation of amygdala GluR1 may be important in the pathophysiology of anxiety disorders.
Introduction
The amygdala is a key limbic structure that is strongly implicated in the pathophysiology of epilepsy [1, 2] , mood, and anxiety disorders [3] . The amygdala functions as a convergence point for sensory input that determines the emotional salience of the input. The emotional content of sensory information is relayed to cortical and brainstem areas involved in fear to coordinate appropriate physiological and behavioral responses to environmental danger [4, 5] . However, hyperexcitability of amygdala circuitry has been shown in temporal lobe epilepsy [2] . Patients with temporal lobe epilepsy may have comorbid psychiatric symptoms [6] , and antiepileptic drugs can be therapeutic in psychiatric disorders [7] . In addition, in the kindling model of epilepsy, seizures are associated with abnormal emotional behaviors such as increased aggression and anxiety-like behavior [1, 8, 9] . Together, this suggests that epilepsy-like mechanisms may be involved in abnormal emotional conditions. It is, therefore, suggested that anxiety and mood disorders may be the result of subseizure hyperexcitability in the amygdala [3, 10] .
Epilepsy-like mechanisms involve an increased glutamatergic activity, whereas dysfunction in the serotonin [5hydroxytryptamine (5-HT)] system is associated with abnormal emotion [11, 12] . In the amygdala, 5-HT decreases excitability [13, 14] . Conversely, 5-HT deficits increase amygdala excitability [10, 15] and contribute to an abnormal emotional behavior [16, 17] . The molecular mechanisms underlying low 5-HT-induced hyperexcitability have not been elucidated completely. However, it has been shown that changes in amygdala glutamate receptors (GluRs) are critical for conditioned fear [18, 19] and conditioned fear is increased in 5-HT-depleted rats [16] . Therefore, we hypothesized that 5-HT depletion by systemic administration of p-chlorophenylalanine (PCPA) is associated with an increased glutamate receptor expression. Our results show that GluR1 transcription is upregulated in PCPA-treated animals.
Methods

Animals
All experimental animal procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and conform to a protocol approved by Baylor University Animal Care and Use Committee. Male Sprague-Dawley rats of approximately 150 g (n = 6; Harlan, Houston, Texas, USA) were group housed in a lightcontrolled 12-h light/dark cycle and temperature-controlled (231C) room. Food and water were available ad libitum.
Experimental design
Individually housed rats were treated on days 1, 2, and 10 with either PCPA (300 mg/kg, n = 3) or phosphatebuffered saline (PBS, n = 3). On day 14, rats were euthanized by rapid decapitation with a small animal guillotine. Brains were dissected in cold (2-41C) PBS and 2-mm slices containing the basolateral complex of the amygdala (taken between 4.5 and 2.5 mm posterior to Bregma) were dissected on dry ice. Tissue samples were taken bilaterally from the amygdala, dorsal hippocampus, and overlying cortex using a core sampler (1.0-mm diameter). Samples were weighed and flash frozen in dry ice/EtOH and stored at -801C until used.
Primers and plasmids
Primers were obtained from Maxim Biotech (San Francisco, California, USA). The GluR1 forward primer was 5 0 -TCG TAC CAC CAT TTG TTT TTC A-3 0 and the reverse primer for GluR1 was 5 0 -AAG AGG GAC GAG ACC AGA CAA C-3 0 . Primers for 18S rRNA were 5 0 -CCG CAG CTA GGA ATA ATG GAA TAG GAC-3 0 (forward) and 5 0 -GTT AGC ATG CCG AGA GTC TCG TTC-3 0 (reverse).
GluR1 plasmids were a gift from R. L. Huganir (John Hopkins Medical Institute, Baltimore, Maryland, USA). The plasmids were Amp+ and contained a cytomegalovirus promoter. DH5a cells were transformed with plasmids, which were then extracted using Qiaprep spin Miniprep Kit (Qiagen, Valencia, California, USA). Concentrations of the cloned plasmids were measured spectrophotometrically. The plasmids were diagnostically verified by double enzyme digest and polymerase chain reaction (PCR) with specific primers. PCR was performed on a Techne TC512 Thermo Cycler using Sigma RedTaq Jumpstart Ready Mix PCR reaction mix (Sigma, St. Louis, Missouri, USA). Annealing temperature of the PCR reaction was optimized using a gradient of temperatures. PCR was performed using 30 cycles of 941C for 30 s, gradient annealing temperature (ranging from 55.9 to 64.21C) for 30 s and 721C for 5 min. Products were separated on a 1% agarose gel and visualized with ethidium bromide to determine optimal PCR conditions.
Quantitative reverse transcriptase-polymerase chain reaction
Whole-cell RNA was extracted using TRI Reagent (Molecular Research Center Inc., Cincinnati, Ohio, USA) following the manufacturer's instructions. Concentration of total RNA was determined by spectrophotometry (l = 260 nm). Extraction was followed by cDNA synthesis and real-time PCR using Dynamo SYBR Green 2 step qRT-PCR kit (NEB, Ipswich, Massachusetts, USA) in a total reaction volume of 25 ml. Samples were run in duplicates. A 'no template' condition served as a negative control. GluR1-containing plasmids were used to standardize separate runs and 18S rRNA was an internal control. The reaction was performed on a Corbett Rotor-Gene 6000 (Qiagen) with the initial denaturation at 951C 15 min, subsequent denaturation at 941C for 10 s, annealing at 59.41C for 30 s, extension 721C for 30 s, and a final extension at 721C for 10 min. Melting curves were performed at the end of each cycle from 72-951C with 90-s intervals, and showed only a single peak near 801C. PCPA-induced changes in GluR1 transcripts were quantified using the comparative DDC (T) method. The number of cycles to threshold [C (T) ] ranged between 19 and 34 for GluR1 and between 12 and 36 for 18S rRNA. Relative quantity of GluR1 mRNA from each sample was calculated as the difference in C (T) for GluR1 minus C (T) for 18S rRNA [DC (T) ], and calibrated to C (T) of PBS-treated control sample [DDC (T) ]. Fold change in transcription is expressed as 2 [ -DDC(T)] [20] .
Statistical analysis
Student's unpaired t-test (two tailed) was used to compare the relative number of PCR cycles to threshold (DC (T) ) in samples from PCPA and PBS-treated animals in each of the three brain regions examined. Statistical significance is defined as a P value of less than 0.05. Data are reported as the mean ± standard error. Estimates of variance in 2 [ -DDC(T)] were calculated using the mean DDC (T) ± standard error of the mean (SEM) of DDC (T) .
Results
P-chlorophenylalanine treatment increased glutamate receptor 1 expression in the amygdale
Systemic administration of PCPA increases fear potentiation of the startle reflex [16] . As fear conditioning requires upregulation of the GluR1 subunit of 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid (AMPA) receptors [19] we investigated the regulation of GluR1 transcription in PCPA-treated animals by quantitative RT-PCR. Figure 1 shows the number of PCR cycles to detection threshold for GluR1 transcripts relative to 18S rRNA [DC (T) ; see methods] in the amygdala, hippocampus, and cortex. DC (T) was decreased from 6.0 ± 1.4 to 1.6 ± 1.7 cycles [P < 0.05, t(4) = 2.45] in samples from PBS-treated control and PCPA-treated rats, respectively. Fewer PCR cycles to threshold reflects a quantitative increase in the amount of mRNA for GluR1. In hippocampal samples, there was a small, but insignificant decrease in cycle numbers [control: The fold change in GluR1 transcript expression was quantified by the DDC(t) method [20] and is shown in Fig. 2 . Using the DDC (T) method, these data were transformed to reflect quantitative changes in number of GluR1 transcripts. In samples from the amygdala, PCPA treatment is associated with a 21-fold increase (SEM: 7-fold to 69-fold increase) in GluR1 transcripts. GluR1 transcript expression did not differ significantly with PBS/PCPA treatment in either the hippocampus (mean: 20-fold increase in PCPA-treated samples; SEM: 1-fold to 323-fold increase) or the cortex (mean: 7-fold increase in PCPAtreated samples; SEM: 40% decrease to 89-fold increase).
Discussion
In this study, we show that systemic PCPA treatment increases GluR1 transcription in the amygdala. PCPA is a competitive inhibitor of the rate-limiting enzyme in 5-HT synthesis, tryptophan-5-hydroxylase. Chronic administration of PCPA, as used in this study, consistently depletes 5-HT levels in several models. We (Hughes, Tran and Keele, submitted) and others have shown previously that PCPA causes over 90% reduction in 5-HT and its primary metabolite 5-hydroxy-indoleacetic acid [21, 22] . Additionally, 5-HT turnover (the ratio of 5-hydroxy-indoleacetic acid to 5-HT) is significantly reduced in PCPA-treated rats. Furthermore, we have shown previously the PCPA treatment increases both aggressive behavior [17] and learned fear behavior [16] in rats. Altogether, these data suggest that disrupting 5-HT levels results in upregulation of excitatory glutamatergic transmission. The low 5-HTinduced increase in excitability of amygdala neurons may be an important mechanism involved in abnormal emotional behavior [10] .
GluR1 expression has an important role in synaptic plasticity. Upregulation of GluR1 underlies enhanced magnitude of excitatory neurotransmission in hippocampal long-term potentiation [23] . Long-term potentiation in sensory pathways afferent to the amygdala is the neural correlate of learned fear [18] , and thus GluR1 expression is also increased in the amygdala of rodents exhibiting learned fear [19] . In these studies, the upregulation of GluR1 seems to occur without similar changes in GluR2 subunits, as the degree of rectification of glutamatergic synaptic currents is enhanced (reflecting a decrease in the relative contribution of GluR2-containing AMPA-R's), which is also accompanied by increased Ca 2+ -permeability of AMPA receptors. Although the effect of PCPA on GluR2 expression was not determined in this study, our previous results showing that PCPA enhances fear learning suggests that GluR1 expression may be selectively upregulated in PCPA-treated rats.
Although the pharmacological effect of PCPA is selective, we cannot confirm the direct role of 5-HT and/or 5-HT receptors in the observed increase of GluR1 transcripts. 5-HT systems are known to interact (crosstalk) with other aminergic systems. For example, it has been shown that 5-HT receptors can modulate mesolimbic dopamine synthesis [24] . As the amygdala receives dopamine-ergic input from the midbrain [25] , an alternate explanation of our data may involve changes in dopamine levels as the critical determinant of GluR1 transcription. That is, in the absence of 5-HT in PCPA-treated animals, dopamine synthesis (and release) could be enhanced, and it is the increased dopamine concentration in the amygdala that initiates the signal transduction cascade causing upregulation of GluR1 transcription. However, the distribution of postsynaptic dopamine and 5-HT receptors in the amygdala argue against this possibility. Dopamine receptors are located primarily on inhibitory GABAergic interneurons but 5-HT receptors are located on both interneurons and glutamatergic projection neurons. The activation of 5-HT receptors on interneurons are depolarizing and increase GABA release [13, 14] , whereas 5-HT receptors on glutamatergic neurons are hyperpolarizing [14] . In light of the differential distribution of receptors, the most parsimonious interpretation of our data is that an increased transcription of GluR1 in PCPAtreated rats is a direct result of 5-HT depletion.
5-HT has primarily an inhibitory role on amygdala output, by both increasing local-circuit GABAergic inhibition and by decreasing glutamatergic excitatory output. 5-HT depletion, therefore, can increase excitability by removing these acute inhibitory components. In-vitro recordings from 
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The relative expression of glutamate receptor 1 (GluR1) transcripts is increased in the amygdala of p-chlorophenylalanine (PCPA)-treated animals (n = 3, stippled bars). mRNA levels were analyzed by quantitative reverse transcriptase polymerase chain reaction and normalized using the DDC (T) method [20] . PCPA-induced increase in GluR1 transcripts is expressed as fold change relative to samples from phosphate-buffered saline-treated control animals (n = 3, open bars) in samples from the amygdala (left) hippocampus (middle), and cortex (right).
amygdala neurons of PCPA-treated rats are consistent with low 5-HT-induced hyperexcitability [15] . Herein our data reveal an additional mechanism of low 5-HT-induced hyperexcitability, where GluR1 transcription is increased following chronic 5-HT depletion. This further suggests that there may be several avenues whereby dysfunction of 5-HTergic mechanisms can increase excitability in the amygdala, both directly at the level of the membrane, and indirectly through changing gene expression. We and others [3, 9, 10] have suggested that hyperexcitability in the amygdala circuitry mediating fear could lead to symptoms of mood and anxiety disorders. Increased transcription of GluR1 may be an important biological correlate involved in these disorders where regulation of 5-HT systems is perturbed.
Conclusion
GluR1 transcription is enhanced 21-fold in the amygdala of rats treated chronically with PCPA to deplete brain serotonin (5-HT). These data suggest that increased GluR1 may underlie amygdala hyperexcitability involved in psychiatric disorders, such as mood and anxiety disorders, where 5-HT function is disrupted.
